- Safety and Efficacy of a New Ultrathin Sirolimus-Eluting Stent with Abluminal Biodegradable Polymer in Real-World Practice
-
Youn YJ, Yoo SY, Lee JW, Ahn SG, Lee SH, Yoon J, Park JH, Choi WG, Cho S, Lim SW, Jang YS, Kwon KH, Lee NH, Doh JH, Kang WC, Jeon DW, Lee BK, Heo JH, Hong BK, Choi HH
- KMID: 2471281
- Korean Circ J.
- 2020 Apr;50(4):317-327.
- doi: 10.4070/kcj.2019.0258
BACKGROUND AND OBJECTIVES: Recently, Genoss drug-eluting stent (DES)â„¢ stent comprising cobalt-chromium platform with an ultrathin strut thickness, sirolimus, and an abluminal biodegradable polymer was developed. Owing to the lack of... -
- CITED
-
- Close
- SHARE
-
- Close
- Clopidogrel versus Aspirin after Dual Antiplatelet Therapy in Acute Myocardial Infarction Patients Undergoing Drug-Eluting Stenting
-
Sim DS, Jeong MH, Kim HS, Gwon HC, Seung KB, Rha SW, Chae SC, Kim CJ, Cha KS, Park JS, Yoon JH, Chae JK, Joo SJ, Choi DJ, Hur SH, Seong IW, Cho MC, Kim DI, Oh SK, Ahn TH, Hwang JY, on behalf of the KAMIR-NIH registry investigators
- KMID: 2468037
- Korean Circ J.
- 2020 Feb;50(2):120-129.
- doi: 10.4070/kcj.2019.0166
BACKGROUND AND OBJECTIVES: There is a paucity of data regarding the benefit of clopidogrel monotherapy after dual antiplatelet therapy (DAPT) in patients treated with drug-eluting stents (DES). This study compared... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-Term Outcomes in Patients Undergoing Percutaneous Coronary Intervention with or without Preprocedural Exercise Stress Test
-
Kim J, Lee JM, Park TK, Yang JH, Song YB, Choi JH, Choi SH, Gwon HC, Lee SH, Hahn JY
- KMID: 2466580
- J Korean Med Sci.
- 2020 Jan;35(1):e3.
- doi: 10.3346/jkms.2020.35.e3
BACKGROUND: Although current guidelines recommend noninvasive stress tests prior to elective percutaneous coronary intervention (PCI), it is unknown whether antecedent exercise stress test (EST) affects the outcomes of patients undergoing... -
- CITED
-
- Close
- SHARE
-
- Close
- SYNTAX Score and SYNTAX Score II Can Predict the Clinical Outcomes of Patients with Left Main and/or 3-Vessel Disease Undergoing Percutaneous Coronary Intervention in the Contemporary Cobalt-Chromium Everolimus-Eluting Stent Era
-
Kang J, Han JK, Kang DY, Zheng C, Yang HM, Park KW, Kang HJ, Koo BK, Kim HS
- KMID: 2465660
- Korean Circ J.
- 2020 Jan;50(1):22-34.
- doi: 10.4070/kcj.2019.0097
BACKGROUND AND OBJECTIVES: The impact of SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery score (SS) and SS II in patients who receive percutaneous coronary intervention with second-generation... -
- CITED
-
- Close
- SHARE
-
- Close
- Use of Paclitaxel Eluting Stents in Arteriovenous Fistulas: A Pilot Study
-
Dinh K, Thomas SD, Cho T, Swinnen J, Crowe P, Varcoe RL
- KMID: 2469222
- Vasc Spec Int.
- 2019 Dec;35(4):225-231.
- doi: 10.5758/vsi.2019.35.4.225
PURPOSE: We report short-term patency outcomes of a proof of concept study conducted to determine the efficacy of drug-eluting stent (DES) for the treatment of arteriovenous fistula (AVF) stenosis in... -
- CITED
-
- Close
- SHARE
-
- Close
- Intravascular Ultrasound-Guided Treatment for In-stent Restenosis Associated with Stent Fracture in Overlapped Drug-eluting Stents
-
Kim MC, Jeong MH, Sim DS, Hong YJ, Kim JH, Ahn Y
- KMID: 2458570
- Chonnam Med J.
- 2019 Sep;55(3):165-167.
- doi: 10.4068/cmj.2019.55.3.165
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Coronary Artery Aneurysm after Second-Generation Drug-Eluting Stent Implantation
-
Hong SJ, Kim H, Ahn CM, Kim JS, Kim BK, Ko YG, Hong BK, Choi D, Jang Y, Hong MK
- KMID: 2457478
- Yonsei Med J.
- 2019 Sep;60(9):824-831.
- doi: 10.3349/ymj.2019.60.9.824
PURPOSE: We evaluated the incidence, predictors, and prognosis of coronary artery aneurysm (CAA) after second-generation drug-eluting stent (DES) implantation. MATERIALS AND METHODS: A total of 976 consecutive patients (1245 lesions) who... -
- CITED
-
- Close
- SHARE
-
- Close
- Diffuse Long Coronary Artery Disease is Still an Obstacle for Percutaneous Coronary Intervention in the Second-Generation Drug-Eluting Stent Era?
-
Oh PC, Han SH
- KMID: 2456866
- Korean Circ J.
- 2019 Aug;49(8):721-723.
- doi: 10.4070/kcj.2019.0150
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Effectiveness and Safety of Zotarolimus-Eluting Stent (Resoluteâ„¢ Integrity) in Patients with Diffuse Long Coronary Artery Disease
-
Park KH, Ahn Y, Koh YY, Ki YJ, Kim SS, Kim HK, Choi DH, Hong YJ, Hwang JY, Kim DH, Rhew JY, Ryu JK, Park JS, Park TH, Yang TH, Oh SK, Lee BR, Lee SU, Lee SG, Chun KJ, Cho JH, Cha KS, Chae JK, Hur SH, Hwang SH, Park HS, Kim DI
- KMID: 2456865
- Korean Circ J.
- 2019 Aug;49(8):709-720.
- doi: 10.4070/kcj.2019.0018
BACKGROUND AND OBJECTIVES: Diffuse long coronary artery disease (DLCAD) still has unfavorable clinical outcomes after successful percutaneous coronary intervention (PCI). Therefore, we aimed to evaluate the effectiveness and safety of... -
- CITED
-
- Close
- SHARE
-
- Close
- Safety Evaluation of Paclitaxel-Eluting Biliary Metal Stent with Sodium Caprate in Porcine Biliary Tract
-
Jang SI, Jeong S, Lee DH, Na K, Yang S, Lee DK
- KMID: 2458531
- Gut Liver.
- 2019 Jul;13(4):471-478.
- doi: 10.5009/gnl18454
BACKGROUND/AIMS: Metallic stents designed to relieve malignant biliary obstruction are susceptible to occlusive tumor ingrowth or overgrowth. In a previous report, we described metallic stents covered with paclitaxel-incorporated membrane (MSCPM-I,... -
- CITED
-
- Close
- SHARE
-
- Close
- Intravascular imaging analysis of a drug-eluting balloon followed by a bare metal stent compared to a drug-eluting stent for treatment of de novo lesions
-
Choi W, Chae IH, Park JJ, Kim SH, Kang SH, Oh IY, Yoon CH, Cho YS, Youn TJ, Choi DJ
- KMID: 2457312
- Korean J Intern Med.
- 2019 Jul;34(4):819-829.
- doi: 10.3904/kjim.2017.378
BACKGROUND/AIMS: After a study comparing drug-eluting stents (DESs) to sequential treatment with drug-eluting balloons (DEBs) and bare metal stents (BMSs), we retrospectively analysed strut malapposition and neointimal hyperplasia in de... -
- CITED
-
- Close
- SHARE
-
- Close
- Don't Touch My POT!
-
Daggubati , Brahmbhatt K, Rigatelli
- KMID: 2454044
- Korean Circ J.
- 2019 Jun;49(6):495-497.
- doi: 10.4070/kcj.2019.0065
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The Proximal Optimization Technique Improves Clinical Outcomes When Treated without Kissing Ballooning in Patients with a Bifurcation Lesion
-
Yang JH, Lee JM, Park TK, Song YB, Hahn JY, Choi JH, Choi SH, Yu CW, Chun WJ, Oh JH, Koo BK, Jeong JO, Kim HS, Gwon HC
- KMID: 2454043
- Korean Circ J.
- 2019 Jun;49(6):485-494.
- doi: 10.4070/kcj.2018.0352
BACKGROUND AND OBJECTIVES: There are limited data regarding the clinical efficacy of the proximal optimization technique (POT) in the treatment of coronary bifurcation lesions. We investigated the influence of POT... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Cardiac Rehabilitation on Outcomes in Patients with ST-Elevation Myocardial Infarction
-
Lee HY, Hong SJ, Jung IH, Kim GS, Byun YS, Kim BO
- KMID: 2446958
- Yonsei Med J.
- 2019 Jun;60(6):535-541.
- doi: 10.3349/ymj.2019.60.6.535
PURPOSE: Whether cardiac rehabilitation (CR) improves clinical outcomes in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) with drug-eluting stents (DESs) has not been thoroughly evaluated.... -
- CITED
-
- Close
- SHARE
-
- Close
- Influence of Local Myocardial Infarction on Endothelial Function, Neointimal Progression, and Inflammation in Target and Non-Target Vascular Territories in a Porcine Model of Acute Myocardial Infarction
-
Kim HK, Kim HB, Lee JM, Kim SS, Bae IH, Park DS, Park JK, Shim JW, Na JY, Lee MY, Kim JS, Sim DS, Hong YJ, Nam CW, Doh JH, Park J, Koo BK, Kim SU, Lim KS, Jeong MH
- KMID: 2445803
- J Korean Med Sci.
- 2019 May;34(19):e145.
- doi: 10.3346/jkms.2019.34.e145
BACKGROUND: Patients with acute myocardial infarction (AMI) have worse clinical outcomes than those with stable coronary artery disease despite revascularization. Non-culprit lesions of AMI also involve more adverse cardiovascular events.... -
- CITED
-
- Close
- SHARE
-
- Close
- Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting for the Treatment of Left Main Coronary Artery Disease
-
Cho SC, Park DW, Park SJ
- KMID: 2444958
- Korean Circ J.
- 2019 May;49(5):369-383.
- doi: 10.4070/kcj.2019.0112
Severe stenosis of the left main coronary artery (LMCA) generally occurs as a result of atherosclerosis and compromises the blood supply to a wide area of myocardium, thereby increasing the... -
- CITED
-
- Close
- SHARE
-
- Close
- Cerebrovascular Drug-Eluting Stent versus Bare-Metal Stent in the Treatment of Vertebral Artery Stenosis: A Non-Inferiority Randomized Clinical Trial
-
He Y, Li T, Bai W, Zhu L, Wang M, Zhang Y
- KMID: 2438654
- J Stroke.
- 2019 Jan;21(1):101-104.
- doi: 10.5853/jos.2018.00479
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Successful Drug-Eluting Stent Overexpansion with Intravascular Ultrasound Guidance for Left Main Bifurcation Lesion Via Left Snuffbox Approach
-
Kim Y, Jeong MH, Kim MC, Sim DS, Hong YJ, Kim JH, Ahn Y
- KMID: 2432260
- Chonnam Med J.
- 2019 Jan;55(1):66-67.
- doi: 10.4068/cmj.2019.55.1.66
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Safety and Efficacy of Biodegradable Polymer-biolimus-eluting Stents (BP-BES) Compared with Durable Polymer-everolimus-eluting Stents (DP-EES) in Patients Undergoing Complex Percutaneous Coronary Intervention
-
Song PS, Park KT, Kim MJ, Jeon KH, Park JS, Choi RK, Song YB, Choi SH, Choi JH, Lee SH, Gwon HC, Jeong JO, Im ES, Kim SW, Chun WJ, Oh JH, Hahn JY
- KMID: 2430749
- Korean Circ J.
- 2019 Jan;49(1):69-80.
- doi: 10.4070/kcj.2018.0097
BACKGROUND AND OBJECTIVES: There are no data comparing clinical outcomes of complex percutaneous coronary intervention (PCI) between biodegradable polymer-biolimus-eluting stents (BP-BES) and durable polymer-everolimus-eluting stents (DP-EES). We sought to evaluate... -
- CITED
-
- Close
- SHARE
-
- Close
- Two-year Clinical Outcomes Following Everolimus-eluting Stent Use for Off-label Versus On-label Indications: From the Korean Multicenter Drug-eluting Stent Registry
-
Pae JY, Lee CH, Choi JY, Park HS, Kim DK, Hyun DW, Jeong YS, Lee SK, Kim YJ, Kim KB
- KMID: 2437304
- Keimyung Med J.
- 2018 Dec;37(2):49-60.
- doi: 10.0000/kmj.2018.37.2.49
BACKGROUND: Everolimus-eluting stent (EES) implantations have a relatively low rate of major adverse cardiac event (MACE) and target lesion revascularization (TLR) in patients with off-label use. However, the clinical outcome... -
- CITED
-
- Close
- SHARE
-
- Close
